Aster Capital Management DIFC Ltd Sells 6,000 Shares of iShares Biotechnology ETF $IBB

Aster Capital Management DIFC Ltd decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 45.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 7,210 shares of the financial services provider’s stock after selling 6,000 shares during the quarter. Aster Capital Management DIFC Ltd’s holdings in iShares Biotechnology ETF were worth $1,217,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $25,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $26,000. Cary Street Partners Financial LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $29,000. Copia Wealth Management bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $34,000. Finally, Cornerstone Planning Group LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $35,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.9%

IBB stock opened at $172.17 on Tuesday. iShares Biotechnology ETF has a fifty-two week low of $123.61 and a fifty-two week high of $179.64. The stock has a fifty day moving average of $170.34 and a 200-day moving average of $170.66.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Monday, June 15th will be issued a dividend of $0.0238 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.